收藏切换
Research progress on the treatment of polycystic ovary syndrome by traditional Chinese medicine regulating NLRP3 inflammasome
收藏切换
PDF
Chong-chong PEI, Ying-ping LIU, Yan WANG, Cai-feng XU, Jun ZHENG
Chinese Journal of Clinical Pharmacology | 2026, 42(8) : 1182 - 1188
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(8): 1182-1188
Review
Research progress on the treatment of polycystic ovary syndrome by traditional Chinese medicine regulating NLRP3 inflammasome
Full
Chong-chong PEI, Ying-ping LIU, Yan WANG, Cai-feng XU, Jun ZHENG
Affiliations
  • Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730000, Gansu Province, China
Published: 2026-04-28 doi: 10.13699/j.cnki.1001-6821.2026.08.021
Outline
收藏切换

Polycystic ovary syndrome (PCOS), a prevalent endocrine-metabolic disorder, is characterized by hyperandrogenemia, ovulatory dysfunction, and polycystic ovarian morphology. The nucleotide-binding leucine-rich repeat (NLR) family pyrin domain containing 3 (NLRP3) inflammasome, an intracellular complex composed of active-NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC) and pro-cysteine aspartate specific proteinase 1 (Pro-Caspase-1), is activated by stimuli such as pathogen invasion, oxidative stress, and metabolic disorders, regulating the release of pro-inflammatory cytokines including interleukin-1β (IL-1β) and IL-18 to mediate inflammatory responses. PCOS is intricately linked to NLRP3 inflammasome activation: it triggers NLRP3 via mechanisms including ion imbalance, mitochondrial dysfunction, and metabolic product accumulation, leading to the release of pro-inflammatory factors that exacerbate ovarian inflammatory microenvironment, inhibit follicular development, and induce granulosa cell apoptosis. Concurrently, NLRP3 inflammasome activation exacerbates metabolic disorders and reproductive endocrine abnormalities by disrupting insulin signaling and promoting androgen synthesis, forming a "metabolism-inflammation-reproduction" vicious cycle. This paper systematically reviews the basic research progress of traditional Chinese medicine (TCM) in regulating NLRP3 inflammasome and deeply explores the synergistic mechanisms of TCM in anti-inflammatory and metabolic regulation within PCOS models, aiming to provide novel therapeutic strategies for PCOS.

traditional Chinese medicine  /  polycystic ovary syndrome  /  NLR family pyrin domain containing 3 inflammasome  /  treatment
Chong-chong PEI, Ying-ping LIU, Yan WANG, Cai-feng XU, Jun ZHENG. Research progress on the treatment of polycystic ovary syndrome by traditional Chinese medicine regulating NLRP3 inflammasome[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (8) : 1182 -1188 . DOI: 10.13699/j.cnki.1001-6821.2026.08.021
Year 2026 volume 42 Issue 8
PDF
134
31
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.08.021
  • Receive Date:2026-01-22
  • Online Date:2026-08-06
  • Published:2026-04-28
Article Data
Affiliations
History
  • Received:2026-01-22
Funding
Affiliations
    Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730000, Gansu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.08.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT